Literature DB >> 19743495

Early treatment for non-ST-segment elevation acute coronary syndrome is associated with appropriate discharge care.

Gregory J Fermann1, Ali S Raja, Eric D Peterson, Matthew T Roe, James W Hoekstra, Sarah Milford-Beland, Deborah B Diercks, Charles V Pollack, W Frank Peacock, Richard Summers, E Magnus Ohman, W Brian Gibler.   

Abstract

BACKGROUND: Acute treatment is associated with improved in-hospital outcomes for patients with non-ST-segment elevation acute coronary syndrome (NSTE ACS). HYPOTHESIS: Patients who receive appropriate acute treatment are more likely to receive guideline-recommended therapy at hospital discharge.
METHODS: Use of aspirin (ASA), beta-blockers, and clopidogrel was evaluated in the first 24 hours and upon hospital discharge according to the 2002 American College of Cardiology/American Heart Association (ACC AHA) guidelines for NSTE ACS. We compared the relationship between 3 groups: (1) ASA therapy given in the emergency department (ED); (2) ASA therapy not given in the ED, but within the first 24 hours; and (3) no acute ASA treatment. The ASA data set includes 10,468 high risk patients with positive cardiac biomarkers or ischemic ST-segment changes on ECG from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the ACC/AHA Guidelines (CRUSADE) Quality Improvement Initiative. Beta-blocker therapy was evaluated in 11,838 and clopidogrel treatment in 17,513 patients presenting to over 345 US hospitals.
RESULTS: Patients who received acute ASA in the ED, ASA in the first 24 hours but not in the ED, and patients who did not receive ASA therapy within 24 hours had discharge ASA treatment rates of 91.8%, 91.4%, and 55.6%, respectively (P < 0.0001). Patients eligible for beta-blocker and clopidogrel therapy had discharge beta-blocker treatment rates of 91.1%, 92.4%, and 46.6% (P < 0.0001), and discharge clopidogrel treatment rates of 86.6%, 92.4%, and 38.5% (P < 0.0001), respectively.
CONCLUSIONS: Acute treatment for NSTE ACS in-hospital is associated with appropriate treatment on hospital discharge. This link between early treatment and discharge therapy may lead to new approaches ensuring the delivery of high-quality, guideline-based care for patients with NSTE ACS. Copyright 2009 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19743495      PMCID: PMC6653545          DOI: 10.1002/clc.20629

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  9 in total

1.  Association between hospital process performance and outcomes among patients with acute coronary syndromes.

Authors:  Eric D Peterson; Matthew T Roe; Jyotsna Mulgund; Elizabeth R DeLong; Barbara L Lytle; Ralph G Brindis; Sidney C Smith; Charles V Pollack; L Kristin Newby; Robert A Harrington; W Brian Gibler; E Magnus Ohman
Journal:  JAMA       Date:  2006-04-26       Impact factor: 56.272

2.  Time to positivity of a rapid bedside assay for cardiac-specific troponin T predicts prognosis in acute coronary syndromes: a Thrombolysis in Myocardial Infarction (TIMI) 11A substudy.

Authors:  E M Antman; D B Sacks; N Rifai; C H McCabe; C P Cannon; E Braunwald
Journal:  J Am Coll Cardiol       Date:  1998-02       Impact factor: 24.094

3.  Improving the care of patients with non-ST-elevation acute coronary syndromes in the emergency department: the CRUSADE initiative.

Authors:  James W Hoekstra; Charles V Pollack; Matthew T Roe; Eric D Peterson; Ralph Brindis; Robert A Harrington; Robert H Christenson; Sidney C Smith; E Magnus Ohman; W Brian Gibler
Journal:  Acad Emerg Med       Date:  2002-11       Impact factor: 3.451

4.  Recent trends in the care of patients with non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE initiative.

Authors:  Rajendra H Mehta; Matthew T Roe; Anita Y Chen; Barbara L Lytle; Charles V Pollack; Ralph G Brindis; Sidney C Smith; Robert A Harrington; Dan Fintel; Elizabeth S Fraulo; Robert M Califf; W Brian Gibler; E Magnus Ohman; Eric D Peterson
Journal:  Arch Intern Med       Date:  2006-10-09

Review 5.  Changing the model of care for patients with acute coronary syndromes.

Authors:  Matthew T Roe; E Magnus Ohman; Charles V Pollack; Eric D Peterson; Ralph G Brindis; Robert A Harrington; Robert H Christenson; Sidney C Smith; Robert M Califf; W Brian Gibler
Journal:  Am Heart J       Date:  2003-10       Impact factor: 4.749

6.  ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina).

Authors:  Eugene Braunwald; Elliott M Antman; John W Beasley; Robert M Califf; Melvin D Cheitlin; Judith S Hochman; Robert H Jones; Dean Kereiakes; Joel Kupersmith; Thomas N Levin; Carl J Pepine; John W Schaeffer; Earl E Smith; David E Steward; Pierre Theroux; Raymond J Gibbons; Joseph S Alpert; David P Faxon; Valentin Fuster; Gabriel Gregoratos; Loren F Hiratzka; Alice K Jacobs; Sidney C Smith
Journal:  Circulation       Date:  2002-10-01       Impact factor: 29.690

7.  Influence of inpatient service specialty on care processes and outcomes for patients with non ST-segment elevation acute coronary syndromes.

Authors:  Matthew T Roe; Anita Y Chen; Rajendra H Mehta; Yun Li; Ralph G Brindis; Sidney C Smith; John S Rumsfeld; W Brian Gibler; E Magnus Ohman; Eric D Peterson
Journal:  Circulation       Date:  2007-08-20       Impact factor: 29.690

8.  Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy in Heart Failure (IMPACT-HF) trial.

Authors:  Wendy A Gattis; Christopher M O'Connor; Dianne S Gallup; Vic Hasselblad; Mihai Gheorghiade
Journal:  J Am Coll Cardiol       Date:  2004-05-05       Impact factor: 24.094

9.  ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine.

Authors:  Jeffrey L Anderson; Cynthia D Adams; Elliott M Antman; Charles R Bridges; Robert M Califf; Donald E Casey; William E Chavey; Francis M Fesmire; Judith S Hochman; Thomas N Levin; A Michael Lincoff; Eric D Peterson; Pierre Theroux; Nanette Kass Wenger; R Scott Wright; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Jeffrey L Anderson; Elliott M Antman; Jonathan L Halperin; Sharon A Hunt; Harlan M Krumholz; Frederick G Kushner; Bruce W Lytle; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel
Journal:  J Am Coll Cardiol       Date:  2007-08-14       Impact factor: 24.094

  9 in total
  2 in total

1.  Compliance of pharmacological treatment for non-ST-elevation acute coronary syndromes with contemporary guidelines: influence on outcomes.

Authors:  Hélder Dores; Carlos Aguiar; Jorge Ferreira; Jorge Mimoso; Sílvia Monteiro; Filipe Seixo; José Ferreira Santos
Journal:  Cardiovasc Diagn Ther       Date:  2014-02

2.  Use of evidence-based interventions in acute coronary syndrome - Subanalysis of the ACCEPT registry.

Authors:  Ricardo Wang; Fernando Carvalho Neuenschwander; Augusto Lima Filho; Celsa Maria Moreira; Elizabete Silva dos Santos; Helder Jose Lima Reis; Edson Renato Romano; Luiz Alberto Piva e Mattos; Otávio Berwanger; Jadelson Pinheiro de Andrade
Journal:  Arq Bras Cardiol       Date:  2014-02-17       Impact factor: 2.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.